IRIS - Res&Arch Institutional Research Information System - Research & Archive

CHIASSERINI, DAVIDE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.404
AS - Asia 2.717
EU - Europa 2.333
SA - Sud America 494
Continente sconosciuto - Info sul continente non disponibili 280
AF - Africa 62
OC - Oceania 6
Totale 9.296
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.305
SG - Singapore 1.274
IT - Italia 536
IE - Irlanda 423
CN - Cina 399
BR - Brasile 387
HK - Hong Kong 340
RU - Federazione Russa 302
VN - Vietnam 246
FR - Francia 199
DE - Germania 197
UA - Ucraina 157
SE - Svezia 119
FI - Finlandia 118
BD - Bangladesh 92
KR - Corea 84
GB - Regno Unito 67
IN - India 53
CA - Canada 51
RO - Romania 48
TR - Turchia 44
IQ - Iraq 40
AR - Argentina 37
NL - Olanda 30
AT - Austria 29
MX - Messico 20
PL - Polonia 20
CH - Svizzera 19
SA - Arabia Saudita 19
ZA - Sudafrica 19
ES - Italia 18
JP - Giappone 18
VE - Venezuela 18
ID - Indonesia 17
PK - Pakistan 16
CL - Cile 15
CZ - Repubblica Ceca 13
EC - Ecuador 13
UZ - Uzbekistan 12
BE - Belgio 11
CO - Colombia 10
KE - Kenya 8
AE - Emirati Arabi Uniti 7
JO - Giordania 7
MA - Marocco 7
MY - Malesia 7
TN - Tunisia 7
JM - Giamaica 6
LB - Libano 6
AO - Angola 5
CR - Costa Rica 5
IL - Israele 5
PH - Filippine 5
PY - Paraguay 5
DZ - Algeria 4
GR - Grecia 4
NP - Nepal 4
AZ - Azerbaigian 3
BO - Bolivia 3
DK - Danimarca 3
KZ - Kazakistan 3
LT - Lituania 3
NI - Nicaragua 3
PA - Panama 3
PE - Perù 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
CG - Congo 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
EU - Europa 2
GT - Guatemala 2
HN - Honduras 2
OM - Oman 2
PS - Palestinian Territory 2
TJ - Tagikistan 2
TW - Taiwan 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BB - Barbados 1
BH - Bahrain 1
BW - Botswana 1
BZ - Belize 1
CI - Costa d'Avorio 1
CY - Cipro 1
FJ - Figi 1
GA - Gabon 1
GY - Guiana 1
HR - Croazia 1
HT - Haiti 1
HU - Ungheria 1
IR - Iran 1
KG - Kirghizistan 1
Totale 9.006
Salva come PNG Salva come JPEG
Città #
Singapore 957
Dublin 421
Chandler 414
San Jose 358
Hong Kong 339
Ashburn 232
Perugia 216
San Mateo 183
Boardman 152
Santa Clara 146
Moscow 132
Beijing 124
Altamura 93
Lauterbourg 89
Los Angeles 86
Seoul 83
Medford 81
Princeton 81
Munich 78
Jacksonville 74
Wilmington 72
Ho Chi Minh City 71
Lawrence 68
New York 66
The Dalles 63
Dong Ket 59
Des Moines 39
Hanoi 38
Bucharest 34
Piscataway 32
Andover 31
São Paulo 29
Frankfurt am Main 28
Turku 28
Ann Arbor 27
Dallas 25
Phoenix 25
Helsinki 22
Redmond 22
Rome 22
Chennai 21
Denver 20
Izmir 19
Milan 19
Brooklyn 18
Orem 18
San Paolo di Civitate 18
Tokyo 18
Nuremberg 17
Buffalo 16
Council Bluffs 16
Johannesburg 15
Saint Petersburg 15
Warsaw 15
Baghdad 14
Chicago 14
Vienna 14
Amsterdam 13
Montreal 13
Stockholm 13
London 12
Toronto 12
Guangzhou 11
Lappeenranta 11
Belo Horizonte 10
Brussels 10
Falkenstein 10
Hefei 10
Houston 10
Istanbul 10
Norwalk 10
Saint Louis 10
Shanghai 10
Atlanta 9
Boston 9
Manchester 9
Tashkent 9
Brasília 8
Columbus 8
Florence 8
Olomouc 8
Riyadh 8
Amman 7
Caracas 7
Changsha 7
Charlotte 7
Curitiba 7
Dhaka 7
Mexico City 7
Nairobi 7
Poplar 7
Santiago 7
Seattle 7
São José dos Campos 7
Campinas 6
Da Nang 6
Falls Church 6
Miami 6
Măgurele 6
Redwood City 6
Totale 5.798
Salva come PNG Salva come JPEG
Nome #
Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration 175
Analisi del proteoma di carcinomi papillari della tiroide positivi per la mutazione BRAFV600E 148
Biochemical Studies on Human Ornithine Aminotransferase Support a Cell-Based Enzyme Replacement Therapy in the Gyrate Atrophy of the Choroid and Retina 135
Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer's disease. 134
Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patients 134
3-Bromopyruvate treatment induces alterations of metabolic and stress-related pathways in glioblastoma cells 132
Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson’s Disease and Dementia with Lewy Bodies 132
Protein expression changes induced in murine peritoneal macrophages by Group B Streptococcus 128
Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies 128
Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis 128
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers. 123
Cerebrospinal fluid biomarkers in Parkinson disease. 122
Performance of Aβ1-40, Aβ1-42, Total Tau, and Phosphorylated Tau as Predictors of Dementia in a Cohort of Patients with Mild Cognitive Impairment. 121
Effects of central and peripheral inflammation on hippocampal synaptic plasticity 121
Cerebrospinal fluid lysosomal enzymes and α-synuclein in Parkinson's disease. 121
Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson's disease: A systematic review and meta-analysis 120
Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurement 117
Persistent activation of microglia and NADPH drive hippocampal dysfunction in experimental multiple sclerosis 116
Cerebrospinal fluid biomarkers for the diagnosis and prognosis of Parkinson's disease: protocol for a systematic review and individual participant data meta-analysis 116
Crosstalk between long-term sublethal oxidative stress and detrimental inflammation as potential drivers for age-related retinal degeneration 115
Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias. 114
Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease. 113
Cytoskeletal perturbation leads to platelet dysfunction and thrombocytopenia in variant forms of Glanzmann thrombasthenia 111
Identification of differentially expressed proteins in papillary thyroid carcinomas with V600E mutation of BRAF 110
Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia 106
Lysosomal enzyme activities in human brain 105
Fingerprinting Alzheimer's Disease by 1H Nuclear Magnetic Resonance Spectroscopy of Cerebrospinal Fluid 105
Extracellular Vesicles in Aging: An Emerging Hallmark? 104
Proteomic analysis of papillary thyroid carcinoma reveals demodulation of mechanisms regulating cell proliferation, susceptibility to oxidative stress and cellular aggregation 104
L’analisi proteomica del carcinoma papillare della tiroide evidenzia modificazioni dello stato ossidoriduttivo e della struttura delle cellule tumorali 101
Performance Evaluation of an Automated ELISA System for Alzheimer's Disease Detection in Clinical Routine 99
Mitochondria and the link between neuroinflammation and neurodegeneration. 98
Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics 98
Characterization of Two Populations of Prostasomes by Proteomics and Dynamic Light Scattering 97
CSF Biomarkers in Parkinson's disease 96
Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: Do fresh vs frozen samples differ? 96
CSF levels of heart fatty acid binding protein are altered during early phases of Alzheimer's disease. 95
Standardization and harmonization of distributed multi-center proteotype analysis supporting precision medicine studies 95
Biomarkers in Parkinson's disease: From pathophysiology to early diagnosis 94
Identification and Partial Characterization of Two Populations of Prostasomes by a Combination of Dynamic Light Scattering and Proteomic Analysis 93
Role of FABP3 as biomarker in Alzheimer's disease and synucleinopathies 93
Erratum: Persistent activation of microglia and NADPH oxidase drive hippocampal dysfunction in experimental multiple sclerosis (Scientific Reports (2016) 6 (20926) DOI: 10.1038/srep20926) 91
HOPS/TMUB1 Enhances Apoptosis in TP53 Mutation-Independent Setting in Human Cancers 89
A Practical Guide to Immunoassay Method Validation 88
Diagnostic utility of CSF α-synuclein species in Parkinson's disease: Protocol for a systematic review and meta-analysis 87
Role of CSF biomarkers in the diagnosis of prodromal Alzheimer's disease. 86
Sistema immunitario e cefalee primarie 85
Factors influencing the measurement of lysosomal enzymes activity in human cerebrospinal fluid. 85
Molecular characterization of colorectal adenomas reveals POFUT1 as a candidate driver of tumor progression 85
C1q is increased in cerebrospinal fluid-derived extracellular vesicles in Alzheimer's disease: A multi-cohort proteomics and immuno-assay validation study 84
Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease. 84
Origin of α-mannosidase activity in CSF 84
Differential protein expression in glioblastoma cells induced by 3-bromopyruvate 84
Proteomic biomarkers for the detection of endometrial cancer 84
A prostate cancer proteomics database for swath-ms based protein quantification 84
Lysosomal enzymes in PD: further evidence is needed. 81
Investigating alpha-synuclein co-pathology in Alzheimer's disease by means of cerebrospinal fluid alpha-synuclein seed amplification assay 80
Proteomic analysis of papillary thyroid carcinomas reveals demodulation of signal transduction pathways, increased resistance to oxidative stress and gain of invasive phenotype. 80
Fibroblast growth factor-2 levels are elevated in the cerebrospinal fluid of multiple sclerosis patients. 80
Proteomic changes induced by Group B Streptococcus in mouse peritoneal macrophages 80
Role of Lysosomal Enzymes in Parkinson’s Disease: Lesson from Gaucher’s Disease 80
Longitudinal changes in CSF alpha-synuclein species reflect Parkinson's disease progression 80
Comprehensive library generation for identification and quantification of endometrial cancer protein biomarkers in cervico-vaginal fluid 79
Molecular dynamic simulation of the catalytic domain of BRAF in response to activating and inactivating mutation 78
Validation of microRNAs in Cerebrospinal Fluid as Biomarkers for Different Forms of Dementia in a Multicenter Study 78
CSF proteome analysis in multiple sclerosis patients by two-dimensional electrophoresis. 78
Cerebrospinal fluid lipoproteins inhibit α-synuclein aggregation by interacting with oligomeric species in seed amplification assays 77
Expression of ionotropic glutamate receptor GLUR3 and effects of glutamate on MBP- and MOG-specific lymphocyte activation and chemotactic migration in multiple sclerosis patients. 77
Mortalin Inhibition in Experimental Parkinson's Disease 77
Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer's disease continuum 76
Trajectories of CSF and plasma biomarkers across Alzheimer's disease continuum: Disease staging by NF-L, p-tau181, and GFAP 76
Lysosomal Dysfunction and α-Synuclein Aggregation in Parkinson's Disease: Diagnostic Links 76
Urinary Biomarkers and Their Potential for the Non-Invasive Detection of Endometrial Cancer 74
Structural dynamics shape the fitness window of alanine:glyoxylate aminotransferase 73
Italian consensus recommendations for a biomarker-based aetiological diagnosis in mild cognitive impairment patients 73
Proteomic analysis of cerebrospinal fluid extracellular vesicles: A comprehensive dataset 72
Immunological profile of silent brain infarction and lacunar stroke. 70
Phosphatidylethanolamine Binding Protein 1 (PEBP1) in Alzheimer's Disease: ELISA Development and Clinical Validation 69
PROTEOMIC ANALYSIS OF EXTRACELLULAR VESICLES IN ALZHEIMER’S DISEASE CEREBROSPINAL FLUID 69
Immunoassay detection of multiphosphorylated tau proteoforms as cerebrospinal fluid and plasma Alzheimer’s disease biomarkers 64
CSF neurosecretory proteins VGF and neuroserpin in patients with Alzheimer's and Lewy body diseases 64
No diurnal variation of classical and candidate biomarkers of Alzheimer's disease in CSF 64
The use of missing values in proteomic data-independent acquisition mass spectrometry to enable disease activity discrimination 64
Modelli sperimentali 63
Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study 63
Donor natural killer cells trigger production of beta-2-microglobulin to enhance post bone marrow transplant immunity 62
Quantitative SWATH-based proteomic profiling of urine for the identification of endometrial cancer biomarkers in symptomatic women 62
Methods to discover and validate biofluid-based biomarkers in neurodegenerative dementias 60
Required improvements for cerebrospinal fluid-based biomarker tests of Alzheimer's disease 59
Fully automated measurement of plasma Aβ42/40 and p-tau181: Analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohorts 59
Evidence for Elevated Cerebrospinal Fluid ERK1/2 Levels in Alzheimer Dementia. 59
Interferon-β1a protects neurons against mitochondrial toxicity via modulation of STAT1 signaling: electrophysiological evidence. 57
Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer's Disease and Other Neurological Disorders 56
Enhancing mummy ‘palaeobiographies’ though the use of multidisciplinary techniques and approaches 56
Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic Characterization 56
The Clinical Use of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease Diagnosis: The Italian Selfie 55
CSF and plasma Aβ42/40 across Alzheimer's disease continuum: comparison of two ultrasensitive Simoa® assays targeting distinct amyloid regions 54
Detection of endometrial cancer in cervico-vaginal fluid and blood plasma: leveraging proteomics and machine learning for biomarker discovery 53
Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer's disease 52
Kidney Fibrosis and Oxidative Stress: From Molecular Pathways to New Pharmacological Opportunities 51
Totale 8.959
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.957
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.957
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022709 0 124 15 30 9 9 4 193 45 47 102 131
2022/20231.391 87 272 16 118 96 141 3 67 535 3 38 15
2023/2024613 32 65 45 17 8 4 113 33 70 22 94 110
2024/20251.625 30 137 59 77 219 104 72 130 297 90 276 134
2025/20263.709 226 247 214 481 491 309 627 190 355 318 155 96
2026/2027191 85 106 0 0 0 0 0 0 0 0 0 0
Totale 9.296